secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001437749-25-028949
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx subsidiary HOPE Therapeutics completes acquisition of Dura Medical
----------------------------------------------------------------------

- Dura Medical is revenue generating and EBITDA positive; operates clinics in Naples and Ft. Myers.
- Offers ketamine therapy, TMS, Spravato, stellate ganglion blocks for depression and PTSD.
- Participates in VA Community Cares Network; founder Stephen Durand appointed Director of Florida Clinic Operations.
- Combined with pending acquisitions to provide coverage at more than 8 locations on Florida's West Coast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/0001437749-25-028949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774925028949/nrxp20250912_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-028949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer